Safety Alerts & Recalls
What does this mean?
Only the name of the Kapidex capsule is changing. The size, strength, and ingredients of the Dexilant capsule will be the same as the Kapidex capsule. Each capsule of Dexilant will still contain 30 mg or 60 mg of the active ingredient dexlansoprazole.
If you are currently taking Kapidex, you will soon be switched to the product with the new name Dexilant. To prepare for when the Dexilant product is available, you can ask your doctor to write a new prescription for Dexilant at your next routine doctor's appointment. If you don't have an upcoming doctor's appointment, you can ask your pharmacist about switching to Dexilant. Some pharmacies may automatically contact your doctor to make the switch and some pharmacies may want to you to contact your doctor to get a new prescription.
If you have additional questions about the name change, you can contact Takeda at 1-877-TAKEDA-7.
FDA Approves Name Change for Heartburn Drug Kapidex
In April 2010, the name Kapidex (dexlansoprazole) will be changing to Dexilant (dexlansoprazole). Kapidex is a proton pump inhibitor used to treat heartburn and other conditions by reducing the amount of acid produced in the stomach.
Since its approval in January 2009, the US Food and Drug Administration (FDA) has received reports of dispensing errors because Kapidex was confused with two other drugs: Casodex, a prostate cancer drug, and Kadian, a narcotic pain reliever. Takeda (the maker of Kapidex), in coordination with the FDA, determined that a name change would be the best way to minimize future medication errors.
For more information: more information here and